GNE-371

GNE-371 Struktur
1926986-36-8
CAS-Nr.
1926986-36-8
Englisch Name:
GNE-371
Synonyma:
GNE-371;GNE 371,GNE371;GNE-371, 10 mM in DMSO;7H-Pyrrolo[2,3-c]pyridin-7-one, 6-(3-buten-1-yl)-1,6-dihydro-4-[1-methyl-6-(4-morpholinylcarbonyl)-1H-benzimidazol-4-yl]-
CBNumber:
CB54844810
Summenformel:
C24H25N5O3
Molgewicht:
431.49
MOL-Datei:
1926986-36-8.mol

GNE-371 Eigenschaften

Siedepunkt:
737.1±70.0 °C(Predicted)
Dichte
1.36±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
Soluble in DMSO
Aggregatzustand
Solid
pka
15.66±0.40(Predicted)
Farbe
White to off-white

Sicherheit

GNE-371 Chemische Eigenschaften,Einsatz,Produktion Methoden

GNE-371 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


GNE-371 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354
marketing@targetmol.com United States 32435 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6312 58
Aladdin Scientific

tp@aladdinsci.com United States 52923 58
Shanghai Beckham Medical Technology Co., Ltd 13816613772
huahero21@sina.com China 2391 55
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312
liming@bio-fount.com China 9729 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 15317229551
15151849396@163.com China 989 58
Shanghai kadel chemical technology co., LTD 021-4007787-550 400-7787-550
2850202386@qq.com China 10582 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24961 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 11973 58
RD International Technology Co., Limited 18024082417
market@ubiochem.com China 9835 58

  • GNE-371
  • 7H-Pyrrolo[2,3-c]pyridin-7-one, 6-(3-buten-1-yl)-1,6-dihydro-4-[1-methyl-6-(4-morpholinylcarbonyl)-1H-benzimidazol-4-yl]-
  • GNE 371,GNE371
  • GNE-371, 10 mM in DMSO
  • 1926986-36-8
Copyright 2019 © ChemicalBook. All rights reserved